Mosaic ImmunoEngineering (OTCMKTS:CPMV) Shares Up 697.3% – Here’s Why

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) shares rose 697.3% during mid-day trading on Monday . The company traded as high as $0.6735 and last traded at $0.4784. 3,728 shares traded hands during mid-day trading, an increase of 470% from the average session volume of 654 shares. The stock had previously closed at $0.06.

Mosaic ImmunoEngineering Price Performance

The firm has a 50-day simple moving average of $0.61 and a 200 day simple moving average of $0.61. The stock has a market capitalization of $3.62 million, a P/E ratio of -5.56 and a beta of -0.82.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last released its quarterly earnings results on Wednesday, May 20th. The company reported ($0.02) earnings per share for the quarter.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.

Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.